Hospice News September 15, 2021
Private equity investors remain bullish on hospice with no signs of slowing down. However, with a number of high-profile transactions completed or in the works during 2020 and 2021, the number of hospices of scale that are likely to come to market is dwindling. During the next few years, PE firms will likely fix their eyes on smaller operations in what remains a highly fragmented industry.
Private equity hospice transactions rose nearly 25% between 2011 to 2020, according to a recent industry transaction report that M&A advisory firm The Braff Group shared with Hospice News. A number of factors are whetting investors’ appetites for hospice, including the increased acceptance of palliative care services, demographic tailwinds, the changing regulatory landscape, and...